Early Phase Cancer Immunotherapy: Current Cancer Research
Editat de Sandip Pravin Patel, Razelle Kurzrocken Limba Engleză Hardback – 10 noi 2017
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 984.57 lei 39-44 zile | |
| Springer International Publishing – 28 aug 2018 | 984.57 lei 39-44 zile | |
| Hardback (1) | 1085.33 lei 6-8 săpt. | |
| Springer International Publishing – 10 noi 2017 | 1085.33 lei 6-8 săpt. |
Din seria Current Cancer Research
- 5%
Preț: 1112.98 lei - 5%
Preț: 1582.35 lei - 5%
Preț: 728.66 lei - 5%
Preț: 1397.21 lei - 5%
Preț: 1075.62 lei - 5%
Preț: 1071.46 lei - 5%
Preț: 1456.54 lei - 5%
Preț: 1076.34 lei - 5%
Preț: 1423.30 lei - 5%
Preț: 695.06 lei - 5%
Preț: 1078.32 lei - 5%
Preț: 1079.95 lei - 5%
Preț: 1093.42 lei - 5%
Preț: 702.60 lei - 5%
Preț: 1275.32 lei - 5%
Preț: 1082.08 lei - 5%
Preț: 703.32 lei - 5%
Preț: 1151.26 lei - 5%
Preț: 887.22 lei - 5%
Preț: 1581.29 lei - 5%
Preț: 1414.50 lei
Preț: 1085.33 lei
Preț vechi: 1142.45 lei
-5% Nou
Puncte Express: 1628
Preț estimativ în valută:
207.81€ • 216.39$ • 172.42£
207.81€ • 216.39$ • 172.42£
Carte tipărită la comandă
Livrare economică 13-27 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319637563
ISBN-10: 3319637568
Pagini: 331
Ilustrații: XI, 331 p. 24 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.66 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research
Locul publicării:Cham, Switzerland
ISBN-10: 3319637568
Pagini: 331
Ilustrații: XI, 331 p. 24 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.66 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins.- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy.- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies.- Chapter 4 Radiographic Evaluation of Immunotherapy.- Chapter 5 Cellular Therapy.- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation.- Chapter 7 Early Phase Cancer Immunotherapy.- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators.- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials.- Chapter 10 Thoracic Immunotherapy.
Notă biografică
Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science, Chief, Division of Hematology & Oncology, Murray Professor of Medicine, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California, San Diego.
Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Textul de pe ultima copertă
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Caracteristici
Focuses on a state-of-the-art review of early phase clinical trials for cancer immunotherapy Discusses about biomarker selection and combinatorial strategies Discusses about safety/toxicity determination of Phase 2 dosing, endpoints in the setting of psuedoprogession and histology selection as they relate to early phase cancer immunotherapy Features chapters written by internationally-known experts in the field